288 related articles for article (PubMed ID: 17142102)
21. WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function.
Aqeilan RI; Donati V; Palamarchuk A; Trapasso F; Kaou M; Pekarsky Y; Sudol M; Croce CM
Cancer Res; 2005 Aug; 65(15):6764-72. PubMed ID: 16061658
[TBL] [Abstract][Full Text] [Related]
22. WWOX in biological control and tumorigenesis.
Aqeilan RI; Croce CM
J Cell Physiol; 2007 Aug; 212(2):307-10. PubMed ID: 17458891
[TBL] [Abstract][Full Text] [Related]
23. WWOX, a new potential tumor suppressor gene.
Hezova R; Ehrmann J; Kolar Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2007 Jun; 151(1):11-5. PubMed ID: 17690733
[TBL] [Abstract][Full Text] [Related]
24. The influence of the WWOX gene on the regulation of biological processes during endometrial carcinogenesis.
Płuciennik E; Nowakowska M; Gałdyszyńska M; Popęda M; Bednarek AK
Int J Mol Med; 2016 Mar; 37(3):807-15. PubMed ID: 26820701
[TBL] [Abstract][Full Text] [Related]
25. The tumor suppressor WW domain-containing oxidoreductase modulates cell metabolism.
Abu-Remaileh M; Aqeilan RI
Exp Biol Med (Maywood); 2015 Mar; 240(3):345-50. PubMed ID: 25491415
[TBL] [Abstract][Full Text] [Related]
26. WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3.
Gourley C; Paige AJ; Taylor KJ; Ward C; Kuske B; Zhang J; Sun M; Janczar S; Harrison DJ; Muir M; Smyth JF; Gabra H
Cancer Res; 2009 Jun; 69(11):4835-42. PubMed ID: 19458077
[TBL] [Abstract][Full Text] [Related]
27. Diverse effect of WWOX overexpression in HT29 and SW480 colon cancer cell lines.
Nowakowska M; Pospiech K; Lewandowska U; Piastowska-Ciesielska AW; Bednarek AK
Tumour Biol; 2014 Sep; 35(9):9291-301. PubMed ID: 24938873
[TBL] [Abstract][Full Text] [Related]
28. WWOX tumor suppressor gene.
Yang J; Zhang W
Histol Histopathol; 2008 Jul; 23(7):877-82. PubMed ID: 18437686
[TBL] [Abstract][Full Text] [Related]
29. WWOX-mediated apoptosis in A549 cells mainly involves the mitochondrial pathway.
Zhang P; Jia R; Ying L; Liu B; Qian G; Fan X; Ge S
Mol Med Rep; 2012 Jul; 6(1):121-4. PubMed ID: 22484428
[TBL] [Abstract][Full Text] [Related]
30. WW domain-containing oxidoreductase promotes neuronal differentiation via negative regulation of glycogen synthase kinase 3β.
Wang HY; Juo LI; Lin YT; Hsiao M; Lin JT; Tsai CH; Tzeng YH; Chuang YC; Chang NS; Yang CN; Lu PJ
Cell Death Differ; 2012 Jun; 19(6):1049-59. PubMed ID: 22193544
[TBL] [Abstract][Full Text] [Related]
31. Pleiotropic Functions of Tumor Suppressor WWOX in Normal and Cancer Cells.
Abu-Remaileh M; Joy-Dodson E; Schueler-Furman O; Aqeilan RI
J Biol Chem; 2015 Dec; 290(52):30728-35. PubMed ID: 26499798
[TBL] [Abstract][Full Text] [Related]
32. WWOX suppresses prostate cancer cell progression through cyclin D1-mediated cell cycle arrest in the G1 phase.
Lin JT; Li HY; Chang NS; Lin CH; Chen YC; Lu PJ
Cell Cycle; 2015; 14(3):408-16. PubMed ID: 25659037
[TBL] [Abstract][Full Text] [Related]
33. Expression of WW domain-containing oxidoreductase WWOX in pterygium.
Huang YH; Chang NS; Tseng SH
Mol Vis; 2015; 21():711-7. PubMed ID: 26120275
[TBL] [Abstract][Full Text] [Related]
34. 17beta-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo.
Chang NS; Schultz L; Hsu LJ; Lewis J; Su M; Sze CI
Oncogene; 2005 Jan; 24(4):714-23. PubMed ID: 15580310
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms underlying WOX1 activation during apoptotic and stress responses.
Chang NS; Doherty J; Ensign A; Lewis J; Heath J; Schultz L; Chen ST; Oppermann U
Biochem Pharmacol; 2003 Oct; 66(8):1347-54. PubMed ID: 14555208
[TBL] [Abstract][Full Text] [Related]
36. WWOX: its genomics, partners, and functions.
Del Mare S; Salah Z; Aqeilan RI
J Cell Biochem; 2009 Nov; 108(4):737-45. PubMed ID: 19708029
[TBL] [Abstract][Full Text] [Related]
37. Effect of exogenous E2F-1 on the expression of common chromosome fragile site genes, FHIT and WWOX.
Ishii H; Mimori K; Vecchione A; Sutheesophon K; Fujiwara T; Mori M; Furukawa Y
Biochem Biophys Res Commun; 2004 Apr; 316(4):1088-93. PubMed ID: 15044096
[TBL] [Abstract][Full Text] [Related]
38. WWOX: a fragile tumor suppressor.
Schrock MS; Huebner K
Exp Biol Med (Maywood); 2015 Mar; 240(3):296-304. PubMed ID: 25538133
[TBL] [Abstract][Full Text] [Related]
39. Relationship of genetic variant distributions of WW domain-containing oxidoreductase gene with uterine cervical cancer.
Lin YH; Hsiao YH; Wu WJ; Yang SF; Hsu CF; Kang YT; Wang PH
Int J Med Sci; 2018; 15(10):1005-1013. PubMed ID: 30013442
[TBL] [Abstract][Full Text] [Related]
40. Coordinate loss of fragile gene expression in pancreatobiliary cancers: correlations among markers and clinical features.
Bloomston M; Kneile J; Butterfield M; Dillhoff M; Muscarella P; Ellison EC; Melvin WS; Croce CM; Pichiorri F; Huebner K; Frankel WL
Ann Surg Oncol; 2009 Aug; 16(8):2331-8. PubMed ID: 19434452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
